SECURITIES AND EXCHANGE COMMISSION


UNITED STATES SECURITIES AND EXCHANGE COMMISSION


Washington, D.C. 20549


FORM 8-K/A

Amendment No. 1


CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934


Date of Report:  July 29, 2008

Date of earliest event reported:  May 15, 2008


AdCare Health Systems, Inc.

(Exact Name of Registrant as specified in its Charter)


Ohio

(State or Other Jurisdiction

of Incorporation)

333-131542

(Commission file Number)


31-1332119

(IRS Employer Identification No.)


5057 Troy Road, Springfield, Ohio  45502-9032

(Address of principal executive offices)  (Zip code)


Registrant’s Telephone Number, Including Area Code

(937) 964-8974


Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A2. below):

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c)).



1



AdCare Health Systems, Inc. (“AdCare” or the “Company”) filed a report on May 19, 2008 to report the completion of the its acquisition of substantially all the assets of The New Lincoln, Ltd. (“NLL”).  In response to parts (a) and (b) of Item 9.01 of the May 19, 2008, Form 8-K, the Company stated that it intended to file the required financial statements and pro forma financial information within the time period permitted by Item 9.01.  By this amendment to the May 19, 2008, Form 8-K, the Company is providing the required financial statements and pro forma financial information.  The information previously reported in the May 19, 2008, Form 8-K is hereby incorporated by reference in this Form 8-K/A.

Special Note Regarding Forward Looking Statements


Certain statements in this report constitute “forward-looking statements.”  These forward-looking statements involve known or unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of AdCare to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.  Specifically, the actions of competitors and customers and our ability to execute our business plan, and our ability to increase revenues is dependent upon our ability to continue to expand our current business and to expand into new markets, general economic conditions, and other factors.  You can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continues,” or the negative of these terms or other comparable terminology.  Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.  We undertake no obligation to publicly update or review any forward-looking statements, whether as a result of new information, future developments or otherwise.

Item 9.01.  Financial Statements and Exhibits.

a.

Financial Statements of Business Acquired.  The audited financial statements of The New Lincoln, Ltd. for the year ended December 31, 2007 and for the three months ended March 31, 2008 are being filed as Exhibit 99.1 to this Form 8-K/A and are incorporated herein by reference.

b.

Pro Forma Financial Information.  The unaudited pro forma consolidated balance sheet as of December 31, 2007  and as of March 31, 2008, and the unaudited pro forma  consolidated statement of operations for the year ended December 31, 2007 and the three months ended March 31, 2008, are being filed as Exhibit 99.2 to this Form 8-K/A and are incorporated herein by reference.

c.

Exhibits

Exhibit Number

Description of Exhibit

99.1

Financial statements of The New Lincoln, Ltd. for the year ended December 31, 2007 and the three months ended March 31, 2008

99.2

Option and Right of First Refusal Agreement

99.3

Unaudited pro forma financial information




2



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.

Date:  July 29, 2008

ADCARE HEALTH SYSTEMS, INC.

By: /s/Scott Cunningham

Name: Scott Cunningham

Title:  Chief Financial Officer



3



Exhibit 99.1


New Lincoln Lodge, Ltd. DBA

The New Lincoln Lodge Retirement Residence

Financial Statements

Year ended December 31, 2007

And the three months ended March 31, 2008



4



Exhibit 99.2

Option and Right of First Refusal Agreement



5



Exhibit 99.3

UNAUDITED PRO FORMA FINANCIAL INFORMATION

On May 15, 2008, AdCare Health Systems, Inc. (the “Company”), completed the acquisition of 99% ownership in The New Lincoln, Ltd. (“NLL”).  The sole asset of The New Lincoln, Ltd. is the New Lincoln Lodge Retirement Residence (“NLLRR”).  NLLRR is a 53 unit assisted living residence located in Columbus, Ohio.  NLLRR began providing independent living and assisted living services in 1997.

On June 10, 1995, the Company formed New Lincoln Co. (in which the Company owned 49%) to serve as a 1% general partner in NLL.  NLL was formed to acquire, renovate and operate NLLRR.  In January 1999, the Company transferred its interest in New Lincoln, Ltd. to the majority owner.  In connection with the transfer of the Company’s interest in NLL, the Company received a promissory note in the amount of $1,425,000.  The note was due to be paid in full on or prior to December 31, 2004.  At December 31, 2004, the outstanding principal balance was $1,389,935.  The Company granted an extension of the due date to December 31, 2005.

In October, 2005, the terms of the promissory note were retroactively amended.  The amended terms called for interest at 10%, and a lump sum payment of the outstanding principal and accrued interest on December 31, 2006, the maturity date.  The promissory note was personally guaranteed by the owner of the facility.  This note was subsequently extended to December 31, 2007.

On March 7, 2008, the Company entered into a letter of intent to acquire 99% of NLL effective April 1, 2008.  The Company completed the acquisition on May 14, 2008.  


The consideration paid by the Company to NLL was approximately $2,392,000 consisting of $12,500 in cash, the residual value of the Company’s note receivable of approximately $218,000, 1% ownership of NLL which the Company has valued at approximately $6,600, liabilities assumed of approximately $2,144,000 and 25,000 warrants to purchase the Company’s stock at a price equal to the stock price of $1.21.  Preliminarily, the Company has estimated the value of these warrants to be approximately $10,500 using the Black-Scholes option-pricing model.  


Additionally, the Company granted an option and right of first refusal to the seller.  The terms of the agreement include an option to purchase the NLL for a period of two years ending on April 1, 2010 at a price equal to $2,750,000 plus any capital expenditures, cash loans, refinancing charges made to refinance the property.  The Company also granted a right of first refusal for an additional three years ending on April 1, 2013 in the event the seller does not exercise its option to purchase by April 1, 2010.  The right of first refusal grants the seller the opportunity to meet any offer to purchase the property for a period of sixty days from the time the offer is made.  The Company has treated this option and right of first refusal as a contingent liability but has not recorded a liability due to the low probability that the option or right of first refusal will be exercised.


The Company evaluated the acquisition of a 99% interest in New Lincoln Lodge pursuant to FAS 109, “Accounting for Income Taxes”, and determined that the excess of the book carrying value over the Company’s tax basis would result in a deferred tax liability.  The effect of recording the deferred tax liability results in a corresponding decrease to the valuation allowance against the net deferred tax asset on the balance sheet.  Therefore, there is no tax expense or benefit recorded in the statement of operations as it related to the acquisition.



6



The following table summarizes the preliminary fair values of the assets acquired and liabilities assumed:


 

 

March 31, 2008

 

December 31, 2007

 

 

 

 

 

Cash

 

 $   19,813

 

 $    18,980

Prepaid expenses and other

 

      12,246

 

      19,195

Restricted cash

 

36,677

 

49,911

Property, Plant & Equipment

 

 2,740,000

 

  2,740,000

Assets Acquired

 

 2,808,736

 

 2,828,086

 

 

 

 

 

Current portion of notes payable and other debt

 

 $(86,499)

 

 $  (61,936)

Accounts payable and accrued expenses

 

   (88,740)

 

(121,210)

Notes payable and other debt, net of current portion

 

(1,968,343)

 

(1,974,235)

Liabilities Assumed

 

 $(2,143,582)

 

$(2,157,381)

 

 

 

 

 

Net assets acquired

 

$     665,154

 

  $     670,705


The unaudited pro forma statement of operations for the year ended December 31, 2007 has been prepared as if the acquisition had occurred on January 1, 2007.  The unaudited pro forma balance sheet as of December 31, 2007 has been prepared as if the acquisition had occurred on that date.  

The unaudited pro forma statement of operations for the three months ended March 31, 2008 has been prepared as if the acquisition had occurred on January 1, 2008.  The unaudited pro forma balance sheet as of March 31, 2008 has been prepared as if the acquisition had occurred on that date.  

The unaudited pro forma financial information is provided for informational purposes only.  The pro forma information is not necessarily indicative of what the Company’s financial position or results of operations actually would have been had the acquisition been completed at the dates indicated.  In addition, the unaudited pro forma financial information does not purport to project future financial position or operating results of the Company.  No effect has been given in the unaudited pro forma statement of operations for synergistic benefits that may be realized through the combination of the two companies or the costs that may be incurred in integrating their operations.  The unaudited pro forma financial statements should be read in conjunction with the respective historical financial statements and notes thereto for the Company that are filed on Form 10-KSB with the Securities and Exchange Commission and the audited historical financial statements of The New Lincoln, Ltd.,  which are included as Exhibit 99.1 in this Form 8-K/A.

The following unaudited pro forma financial information was prepared using the purchase method of accounting as required by FASB Statement of Financial Accounting Standard No. 141, “Business Combinations”and EITF 04-01 “Accounting for Preexisting Relationships between the Parties to a Business Combination”.  The purchase price has been allocated to the assets acquired and liabilities assumed based upon management’s preliminary estimate of their respective fair values as of the date of acquisition.  Any differences between fair value of the consideration issued and the fair value of the assets and liabilities acquired will be recorded as a gain on the acquisition.  The purchase price and fair value estimates for the purchase price allocation may be refined as additional information becomes available.



7






Unaudited Pro Forma Consolidated Balance Sheet

As of December 31, 2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Historical

 

Pro Forma

 

 

 

 

AdCare

 

NLL

 

Adjustments

 

Consolidated

ASSETS

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

Cash

 $  926,625

 

 $  18,980

 

$    (12,500)

(B)

 $933,105

Certificate of deposit, restricted

     209,637

 

             -   

 

-

 

   209,637

Accounts receivable:

 

 

 

 

 

 

 

 

Long-term care resident receivables, net

   2,115,364

 

                -   

 

-

 

    2,115,364

 

Management, consulting and development receivables, net

259,778

 

                 -   

 

-

 

       259,778

 

Advances and receivables from affiliates, current

         27,558

 

                 -   

 

-

 

         27,558

Prepaid expenses and other

     453,219

 

      19,195

 

-

 

       472,414

 

 

 

Total current assets

   3,992,181

 

      38,175

 

(12,500)   

 

    4,017,856

 

 

 

 

 

 

 

 

 

 

 

Restricted cash

     973,975

 

      49,911

 

-

 

    1,023,886

Property and equipment, net

14,425,868

 

 2,083,247

 

      656,753

(D)

  17,165,868

Note receivable, net

      221,413

 

               -   

 

    (221,413)

(A)

                  -   

License, net

   1,189,307

 

               -   

 

-

 

    1,189,307

Goodwill

   2,638,193

 

               -   

 

-

 

    2,638,193

Other Assets

   1,050,506

 

      76,958

 

(76,958)

(C)

    1,050,506

 

 

 

Total Assets

$24,491,443

 

 $2,248,291

 

 $   345,882

 

$27,085,616

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

Current Liabilities:

 

 

 

 

 

 

 

 

Current portion of notes payable and  other debt

 $   773,279

 

 $    61,936

 

-

 

 $    835,215

 

Current portion of notes payable to stockholders

          9,026

 

                 -   

 

-

 

           9,026

 

Accounts payable and accrued expenses

   3,476,535

 

     163,990

 

      (42,780)

(C)

   3,597,745

 

Forward Purchase Contract

      900,000

 

-

 

-

 

       900,000

 

 

 

Total current liabilities

   5,158,840

 

     225,926

 

      (42,780)

 

    5,341,986

 

 

 

 

 

 

 

 

 

 

 

Notes Payable and Other Debt, Net of Current Portion

 12,813,338

 

  1,974,235

 

-

 

  14,787,573

Notes Payable to Stockholders, Net of Current Portion

      810,084

 

                 -   

 

-

 

       810,084

Other Liabilities

      559,509

 

  2,734,293

 

 (2,723,760)

(C),(F)

570,042

Minority Interest in Equity of Consolidated Entities

      255,070

 

                 -   

 

          6,707

(E)

       261,777

 

 

Total liabilities

 19,596,841

 

  4,934,454

 

(2,759,833)

 

  21,771,462

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

 

Preferred stock, no par value; 500,000 shares authorized;

 

 

no shares issued or outstanding

                  -   

 

                  -

 

-

 

                  -   

 

Common stock and additional paid-in capital, no par value;

 

 

 

 

 

14,500,000 shares authorized; 3,786,129 shares

 

 

 

 

 

 

 

 

 

issued and outstanding

  14,063,956

 

                  -   

 

-

 

  14,063,956

 

Accumulated deficit

 (9,169,354)

 

 (2,686,163)

 

3,105,715

(B),(C)

 (8,749,802)

 

 

Total stockholders' equity

    4,894,602

 

 (2,686,163)

 

   3,105,715

 

    5,314,154

 

 

Total liabilities and stockholders' equity

$24,491,443

 

$ 2,248,291

 

$    345,882

 

$27,085,616

See notes to unaudited pro forma consolidated financial statements.



8




Unaudited Pro Forma Consolidated Statement of Operations

As of December 31, 2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Historical

 

Pro Forma

 

 

 

AdCare

 

NLL

 

Adjustments

 

Consolidated

 

 

 

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

 

 

Patient care revenues

$21,928,808

 

 $   577,244

 

-

 

$22,506,052

 

Management, consulting and development fee revenue

    1,738,948

 

-

 

-

 

    1,738,948

 

 

Total revenue

  23,667,756

 

       577,244

 

                  -   

 

  24,245,000

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

   

 

Payroll and related payroll costs

  14,762,090

 

      285,717

 

-

 

  15,047,807

 

Other operating expenses

    7,746,505

 

       205,938

 

-

 

    7,952,443

 

Depreciation and amortization

       847,440

 

         88,122

 

-

 

935,562

 

 

Total expenses

  23,356,035

 

       579,777

 

-

 

  23,935,812

 

 

 

 

 

 

 

 

 

                    

Income from Continuing Operations

       311,721

 

        (2,533)

 

-

 

       309,188

Other Income (Expense):

 

 

 

 

 

 

 

 

Interest income

         59,300

 

              744

 

-

 

         60,044 

 

Interest expense, others

    (978,731)

 

    (147,899)

 

-

 

(1,126,630)

 

Interest expense, related parties

      (66,432)

 

   (140,934)

 

      140,934

 (G)

     (66,432)

 

Minority interest in earnings of consolidated entities

      (94,811)

 

                 -   

 

-

 

      (94,811)

 

Other income (expense)

      (37,014)

 

                 -   

 

-

 

      (37,014)

 

 

 

 (1,117,688)

 

    (288,089)

 

       140,934

 

 (1,264,843)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on acquisition

                  -   

 

                 -   

 

419,552

(B)

419,552 

Income (Loss) Before Discontinued Operations

    (805,967)

 

    (290,622)

 

560,486

 

    (536,103)

Income Tax Benefit

       178,415

 

                 -   

 

-

 

       178,415 

Loss from Continuing Operations

    (627,552)

 

   (290,622)

 

      560,486

 

    (357,688)

Discontinued Operations:

 

 

 

 

 

 

 

 

Income from discontinued operations (including gain on disposal of $619,605)

       587,039

 

                -   

 

-

 

      587,039 

 

Provision for income taxes

   (178,415)

 

                 -   

 

-

 

    (178,415)

 

 

 

       408,624

 

                 -   

 

                  -   

 

      408,624 

Net Loss

 $ (218,928)

 

 $ (290,622)

 

 $    560,486

 

 $      50,936 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) Per Share, Basic and Diluted:

 

 

 

 

 

 

 

 

Continuing operations

 $       (0.16)

 

 

 

 $          0.15

 

 $       (0.09)

 

Discontinued operations

             0.11

 

 

 

                 -   

 

             0.11 

 

 

 

 $       (0.05)

 

 

 

 $          0.15

 

 $          0.02 

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding,

 

 

 

 

 

 

 

 

Basic

    3,786,129

 

 

 

    3,786,129

 

   3,786,129 

 

Diluted

    3,786,129

 

 

 

    3,786,129

 

    3,786,129 

 

 

 

 

 

 

 

 

 

See notes to unaudited pro forma consolidated financial statements.



9




Unaudited Pro Forma Consolidated Balance Sheet

As of March 31, 2008

 

 

 

 

 

Historical

 

Pro Forma

 

 

 

 

AdCare

 

NLL

 

Adjustments

 

Consolidated

ASSETS

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

Cash

 $   886,000

 

 $   19,813

 

$    (12,500)

(B)

 $    893,313

Certificate of deposit, restricted

      211,998

 

                -   

 

-

 

       211,998

Accounts receivable:

 

 

 

 

 

 

 

 

Long-term care resident receivables, net

   2,197,467

 

                -   

 

-

 

    2,197,467

 

Management, consulting and development receivables, net

      287,950

 

                -   

 

-

 

       287,950

 

Advances and receivables from affiliates, current

        22,669

 

                -   

 

-

 

         22,669

Prepaid expenses and other

      406,927

 

      12,246

 

(3,500)

(B)

       415,673

 

 

 

Total current assets

   4,013,011

 

      32,059

 

      (16,000)   

 

    4,029,070

 

 

 

 

 

 

 

 

 

 

 

Restricted cash

      740,803

 

      36,677

 

-

 

       777,480

Property and equipment, net

 14,378,198

 

 2,067,894

 

       672,106

(D)

  17,118,198

Note receivable, net

      218,015

 

                -   

 

    (218,015)

(A)

                 -

License, net

   1,189,307

 

                -   

 

-

 

    1,189,307

Goodwill

   2,638,193

 

                -   

 

-

 

    2,638,193

Other Assets

   1,151,121

 

      76,297

 

(76,297)

(C)

    1,151,121

 

 

 

Total Assets

$24,328,648

 

$2,212,927

 

 $    361,794

 

$26,903,369

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Current portion of notes payable and  other debt

 $    740,607

 

 $       86,499

 

-

 

 $    827,106

 

Current portion of notes payable to stockholders

           9,432

 

                    -   

 

-

 

           9,432

 

Accounts payable and accrued expenses

    3,485,882

 

       130,270

 

      (41,530)

(C)

    3,574,622

 

Forward Purchase Contract

       900,000

 

 

 

-

 

       900,000

 

 

 

Total current liabilities

    5,135,921

 

        216,769

 

      (41,530)

 

    5,311,160

 

 

 

 

 

 

 

 

 

 

 

Notes Payable and Other Debt, Net of Current Portion

  12,728,438

 

    1,968,343

 

-

 

  14,696,781

Notes Payable to Stockholders, Net of Current Portion

       805,187

 

                    -   

 

-

 

       805,187

Other Liabilities

       569,238

 

     2,774,980

 

 (2,764,446)

(C),(F)

579,772

Deferred Tax Liability

         10,642

 

-

 

-

 

         10,642

Minority Interest in Equity of Consolidated Entities

       307,000

 

                    -   

 

           6,651

(E)

       313,651

 

 

Total liabilities

  19,556,426

 

    4,960,092

 

 (2,799,325)

 

  21,717,193

 

 

 

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

 

Preferred stock, no par value; 500,000 shares authorized; no shares issued or outstanding

                   -   

 

                    -   

 

-

 

                    -   

 

Common stock and additional paid-in capital, no par value;

 

 

14,500,000 shares authorized; 3,786,129 shares issued and outstanding

14,081,044

 

-

 

-

 

  14,081,044

 

Accumulated deficit

(9,308,822)

 

   (2,747,165)

 

3,161,119

(B),(C)

 (8,894,868)

 

 

Total stockholders' equity

    4,772,222

 

   (2,747,165)

 

3,161,119

 

    5,186,176

 

 

Total liabilities and stockholders' equity

$24,328,648

 

$  2,212,927

 

$     361,794

 

$26,903,369

 

 

 

 

 

 

 

 

 

 

See notes to unaudited pro forma consolidated financial statements.



10




Unaudited Pro Forma Consolidated Statement of Operations

As of March 31, 2008

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Historical

 

Pro Forma

 

 

 

AdCare

 

NLL

 

Adjustments

 

Consolidated

Revenues:

 

 

 

 

 

 

 

 

Patient care revenues

 $   5,568,061

 

 $ 159,168

 

-

 

 $ 5,727,229

 

Management, consulting and development fee revenue

         424,481

 

-

 

-

 

        424,481

 

 

Total revenue

      5,992,542

 

    159,168

 

                    -   

 

    6,151,710

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

Payroll and related payroll costs

      3,587,397

 

      77,938

 

-

 

     3,665,335

 

Other operating expenses

     2,023,256

 

      47,241

 

-

 

     2,070,497

 

Depreciation and amortization

         226,694

 

      22,514

 

-

 

        249,208

 

 

Total expenses

      5,837,347

 

    147,693

 

         -

 

     5,985,040

 

 

 

 

 

 

 

 

 

 

Income from Continuing Operations

         155,195

 

      11,475

 

            -

 

        166,670

Other Income (Expense):

 

 

 

 

 

 

 

 

Interest income

             9,133

 

           360

 

-

 

            9,493

 

Interest expense, others

      (226,352)

 

   (36,150)

 

-

 

    (262,502)

 

Interest expense, related parties

        (14,872)

 

   (36,687)

 

          36,687

 (G)

       (14,872)

 

Minority interest in earnings of consolidated entities

        (51,930)

 

              -   

 

-

 

       (51,930)

 

 

 

      (284,021)

 

   (72,477)

 

          36,687

 

     (319,811)

 

 

 

 

 

 

 

 

 

 

Gain On Acquisition

-

 

-

 

413,593

(B)

413,593 

Loss From Continuing Operations Before Income Taxes

      (128,826)

 

   (61,002)

 

        450,280

 

260,452 

Income Tax Expense

        (10,642)

 

              -   

 

-

 

       (10,642)

Net Income (Loss)

 $   (139,468)

 

 $(61,002)

 

 $     450,280

 

 $    249,810 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss) Per Share, Basic and Diluted:

 

 

 

 

 

 

 

 

Continuing operations

 $         (0.04)

 

 

 

 $           0.11

 

 $          0.07

 

Discontinued operations

                    -   

 

 

 

                   -   

 

                   -   

 

 

 

 $         (0.04)

 

 

 

 $           0.11

 

 $          0.07

 

 

 

 

 

 

 

 

 

 

Weighted Average Common Shares Outstanding,

 

 

 

 

 

 

 

 

Basic

     3,786,129

 

 

 

     3,786,129

 

     3,786,129

 

Diluted

      3,786,129

 

 

 

     3,786,129

 

     3,786,129

 

 

 

 

 

 

 

 

 

See notes to unaudited pro forma consolidated financial statements.




11





Notes to Unaudited Pro Forma Consolidated Financial Statements

 

 

 

Adjustments as of

 

 

 

March 31, 2008

 

December 31, 2007

(A)

To eliminate AdCare's note receivable from New Lincoln Lodge

 

 

 

 

 

 

 

Note receivable due from New Lincoln Lodge

 

 $(1,462,288)

 

 $(1,456,686)

 

Allowance for bad debt

 

    1,323,773 

 

    1,323,773 

 

Accrued interest NLL

 

        (79,500)

 

       (88,500)

 

Residual value on note

 

 $   (218,015)

 

 $   (221,413)

 

 

 

 

 

 

(B)

Gain recognized on acquisition in accordance with EITF 04-1, “Accounting for

 

Preexisting Relationships between the Parties to a Business Combination”

 

 

 

 

 

 

 

Cash

 

$      12,500 

 

 $       12,500 

 

Residual value of note

 

       218,015 

 

        221,412 

 

Allocate 1% ownership to minority owner

 

           6,652 

 

            6,707 

 

Liabilities assumed

 

    2,143,582 

 

     2,157,381 

 

Value of warrants granted

 

         10,534 

 

          10,534 

 

Other transaction costs

 

3,500 

 

 

Consideration Given

 

    2,394,783 

 

     2,408,534 

 

Assets acquired

 

    2,808,736 

 

     2,828,086 

 

Gain on acquisition

 

 $   (413,953)

 

 $   (419,552)

 

 

 

 

 

 

(C)

Assets and Liabilities not assumed or eliminated in acquisition as well as equity accounts

 

 

 

 

 

 

 

Financing costs

 

 $      76,297 

 

$       76,958 

 

Other liabilities (note payable and accrued interest to AdCare and affiliates of)

 

$ 2,774,980 

 

$  2,734,293 

 

Accounts payable and accrued expenses

 

 $      41,530 

 

 $       42,780 

 

Equity of NLL-Accumulated deficit

 

 $ 2,747,165 

 

 $  2,686,163 

 

 

 

 

 

 

(D)

Write up property plant and equipment to fair market value

 

 

 

 

 

 

 

 

Property, plant and equipment at fair market value

 

 $ 2,740,000 

 

 $ 2,740,000 

 

Net property, plant and equipment per NLL

 

    2,067,894 

 

2,083,247 

 

   Increase in fair market value

 

 $    672,106 

 

 $    656,753 

 

 

 

 

 

 

(E)

Allocate 1% ownership to minority owner

 

 

 

 

 

 

 

 

 

 

 

Assets Acquired

 

 $ 2,808,736 

 

 $   2,828,086 

 

Less: liabilities assumed

 

   (2,143,582)

 

(2,157,381)

 

 

 

 $    665,154 

 

 $      670,705 

 

1% ownership to minority

 

 $        6,652 

 

 $          6,707 

 

 

 

 

 

 



12




Notes to Unaudited Pro Forma Consolidated Financial Statements

 

 

 

Adjustments as of

 

 

 

March 31, 2008

 

December 31, 2007

(F)

Value of Warrants issued in conjunction with acquisition

 

 

 

 

 

 

 

 

 

 

 

25,000 warrants to purchase the Company's stock at a price equal to the stock price of $1.21.  Preliminarily, the Company has estimated the value to be approximately $10,500 using the Black-Scholes option-pricing model

 

$        10,534

 

$        10,534

 

 

 

(G)

Represents elimination of related party interest expense

 

 

 

 

 

 

 

 

 

 

 

Interest expense, related party

 

 $       36,687

 

 $      140,934


 







13